Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JG.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JG.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JG.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JG.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JG.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBBEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBBECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBBECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBBEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBBEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBBENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FR.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FR.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FR.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used